Manoj Kesarwani, M.D.
Health Sciences Clinical Associate Professor
Value Team Medical Director, Davis 6 Cardiology Services Unit
To see if Manoj Kesarwani is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).
Department
Locations and Contact
Lawrence J. Ellison Ambulatory Care Center
Cardiology Clinic
4860 Y St.
Sacramento, CA 95817
Fax: 800-348-0499
Additional Numbers
Phone
Fax
Clinic Fax
Physician Referrals
Philosophy of Care
Dr. Kesarwani values patient care above all else. He is always willing to take the time necessary to understand the needs and concerns of the patient before him. This involves careful listening and attention to the patient, providing detailed explanations of the treatments being offered, and using a shared-decision making approach in developing a patient-care plan. He is also a firm believer in providing compassionate, individual-based care to his patients. Ultimately, Dr. Kesarwani works to ensure that his patients receive the best possible care in the same way he would want for his own family.
Clinical Interests
Dr. Kesarwani is a board-certified physician in Internal Medicine, Cardiovascular Disease, and Interventional Cardiology. Living by the mantra "patient comes first", Dr. Kesarwani focuses on providing patient-centered care and always utilizes a shared decision-making approach. He also delivers compassionate care to patients with various cardiovascular conditions, including coronary artery disease, structural heart/valvular abnormalities (e.g., hypertrophic cardiomyopathy, aortic stenosis), hypertension, and high cholesterol. He has special clinical interest and expertise in the physiologic assessment of coronary stenosis (i.e, FFR/iFR/RFR), intracoronary imaging (e.g., IVUS/OCT/NIRS), coronary atherectomy, and complex coronary interventions via the radial artery in the wrist.
Research/Academic Interests
Dr. Kesarwani's research focuses on improving cardiovascular outcomes through direct participation in observational studies and clinical trials. He is particularly interested in practice patterns in interventional cadiology that decrease cardiovascular morbidity and mortality with techniques that range from transradial cardiac catheterization to the full spectrum of analyses in coronary physiology. Helping to reduce racial disparities in the management of patients with coronary artery disease is another important research interest in his practice. In addition, Dr. Kesarwani is very passionate about teaching the next generation of cardiovascular specialists as the head instructor for the cardiovascular pathophysiology course in the UC Davis School of Medicine. He is also closely involved in the clinical education of medical students, residents, and cardiovascular disease/interventional cardiology fellows.
Division
Cardiovascular Medicine
Undergraduate School
B.A., Molecular and Cell Biology with Emphasis in Biochemistry, UC Berkeley, Berkeley CA 2001
Medical School
M.D., UC Irvine College of Medicine, Irvine CA 2006
Internship
Internal Medicine, Harbor - UCLA Medical Center, Torrance CA 2006-2007
Residency
Internal Medicine, Harbor - UCLA Medical Center, Torrance CA 2007-2010
Fellowship
Interventional Cardiology, UC San Francisco, San Francisco CA 2013-2015
Fellowship
Cardiovascular Disease, University of Washington, Seattle WA 2010-2013
UC Davis Medical Center Nursing Excellence Award (“Friends of Nursing” Category), 2019
American College of Cardiology Elite Fellows-In-Training Rising Star Award, 2014
Letter of Commendation for Excellence in Medical Student Teaching from the UCLA David Geffen School of Medicine, 2009
Smilowitz NR, Prasad M, Widmer RJ, Toleva O, Quesada O, Sutton NR, Lerman A, Reynolds HR, Kesarwani M, Savage MP, Sweeny JM, Janaszek KB, Barseghian El-Farra A, Holoshitz N, Park K, Albadri A, Blair JA, Jeremias A, Kearney KE, Kobayashi Y, Miner SES, Samuels BA, Shah SM, Taqueti VR, Wei J, Fearon WF, Moses JW, Henry TD, Tremmel JA; Microvascular Network (MVN). Comprehensive Management of ANOCA, Part 2-Program Development, Treatment, and Research Initiatives: JACC State-of-the-Art Review. J Am Coll Cardiol. 2023 Sep 19;82(12):1264-1279. doi: 10.1016/j.jacc.2023.06.044. PMID: 37704316.
Samuels BA, Shah SM, Widmer RJ, Kobayashi Y, Miner SES, Taqueti VR, Jeremias A, Albadri A, Blair JA, Kearney KE, Wei J, Park K, Barseghian El-Farra A, Holoshitz N, Janaszek KB, Kesarwani M, Lerman A, Prasad M, Quesada O, Reynolds HR, Savage MP, Smilowitz NR, Sutton NR, Sweeny JM, Toleva O, Henry TD, Moses JW, Fearon WF, Tremmel JA; Microvascular Network (MVN). Comprehensive Management of ANOCA, Part 1-Definition, Patient Population, and Diagnosis: JACC State-of-the-Art Review. J Am Coll Cardiol. 2023 Sep 19;82(12):1245-1263. doi: 10.1016/j.jacc.2023.06.043. PMID: 37704315.
Kesarwani M. In ACS with multivessel CAD, immediate vs. staged complete revascularization was noninferior for a composite outcome at 1 y. Ann Intern Med. 2023 Jul;176(7):JC76. doi: 10.7326/J23-0049. Epub 2023 Jul 4. Erratum in: Ann Intern Med. 2023 Dec;176(12):JC144. doi: 10.7326/J23-0087. PMID: 37399558.
Kesarwani M. In older adults with recent MI, polypill vs. usual care reduced major adverse CV events at 3 y. Ann Intern Med. 2023 Jan;176(1):JC3. doi: 10.7326/J22-0110. Epub 2023 Jan 3. PMID: 36592472.
Kesarwani M. In patients with high bleeding risk, 1 vs. ≥3 mo of DAPT after complex or noncomplex PCI did not differ for clinical events. Ann Intern Med. 2022 Oct;175(10):JC112. doi:10.7326/J22-0076. Epub 2022 Oct 4. PMID:36191320.
Kesarwani M. Stopping aspirin 1 to 3 mo after PCI reduces bleeding without increasing MACE vs. continued DAPT. Ann Intern Med. 2020 Dec 15;173(12):JC64. doi:10.7326/ACPJ202012150-064. PMID:33316184.
Chiou A, Aman E, Kesarwani M. A case report of an infiltrative cardiomyopathy in everyday practice: a specific cause that cannot be missed in the elderly. Eur Heart J Case Rep. 2020 Nov 24;4(6):1-6. doi:10.1093/ehjcr/ytaa382. PMID:33442642.
Kesarwani M. Out-of-Hospital Cardiac Arrest Due to a Concealed Diagnosis. JACC Case Rep. 2019 Sep 18;1(3):339-342. doi:10.1016/j.jaccas.2019.07.019. PMID:34316821.
Kesarwani M, Nakanishi R, Choi TY, Shavelle DM, Budoff MJ. Evaluation of Plaque Morphology by 64-Slice Coronary Computed Tomographic Angiography Compared to Intravascular Ultrasound in Nonocclusive Segments of Coronary Arteries. Acad Radiol. 2017 Aug;24(8):968-974. doi:10.1016/j.acra.2017.03.001. Epub 2017 Mar 27. PMID:28359681.
Kesarwani M. Beta-Blocker Therapy for Acute Myocardial Infraction and Stable Coronary Artery Disease: Current Issues and Outcomes, Richards, JR, (ed). Beta-Blockers: Physiological, Pharmacological and Therapeutic Implications, Nova Science Publishers. 2018 Jan 1:287-298.